1,501–1,550 of 20,598 genesranked by Most Researched

#	Gene	Name	Chr	Tags	PubMed Papers
1501	ITLN1	intelectin 1	1	Experimental GO EvidenceSwiss-Prot Reviewed	256
1502	NAT1	N-acetyltransferase 1	8	Experimental GO EvidenceSwiss-Prot Reviewed	256
1503	PAX8	paired box 8	2	Transcription FactorOMIM Disease Gene	256
1504	PPIB	peptidylprolyl isomerase B	15	OMIM Disease GeneExperimental GO Evidence	256
1505	TUBA1C	tubulin alpha 1c	12	FDA Approved TargetOMIM Disease Gene	256
1506	CALM3	calmodulin 3	19	Highly ConstrainedFDA Approved Target	255
1507	CD46	CD46 molecule	1	ReceptorOMIM Disease Gene	255
1508	PDE4D	phosphodiesterase 4D	5	FDA Approved TargetOMIM Disease Gene	255
1509	RELN	reelin	7	Highly ConstrainedProtease	255
1510	RPL27A	ribosomal protein L27a	11	Highly ConstrainedFDA Approved Target	255
1511	TPX2	TPX2 microtubule nucleation factor	20	Highly ConstrainedExperimental GO Evidence	255
1512	CD86	CD86 molecule	3	ReceptorFDA Approved Target	254
1513	HAVCR1	hepatitis A virus cellular receptor 1	5	ReceptorExperimental GO Evidence	254
1514	KRT14	keratin 14	17	OMIM Disease GeneVariant-Rich	254
1515	LOX	lysyl oxidase	5	OMIM Disease GeneVariant-Rich	254
1516	PGRMC1	progesterone receptor membrane component 1	X	ReceptorExperimental GO Evidence	254
1517	HAX1	HCLS1 associated protein X-1	1	OMIM Disease GeneTrending	253
1518	NPC1	NPC intracellular cholesterol transporter 1	18	ReceptorTransporter	253
1519	AKT3	AKT serine/threonine kinase 3	1	KinaseOMIM Disease Gene	252
1520	CDKN1C	cyclin dependent kinase inhibitor 1C	11	Tumor SuppressorOMIM Disease Gene	252
1521	FADS1	fatty acid desaturase 1	11	TransporterExperimental GO Evidence	252
1522	IARS1	isoleucyl-tRNA synthetase 1	9	OMIM Disease GeneExperimental GO Evidence	252
1523	MPL	MPL proto-oncogene, thrombopoietin receptor	1	ReceptorFDA Approved Target	252
1524	PRKAA2	protein kinase AMP-activated catalytic subunit alpha 2	1	KinaseFDA Approved Target	252
1525	RAB1A	RAB1A, member RAS oncogene family	2	Highly ConstrainedTransporter	252
1526	TRIM5	tripartite motif containing 5	11	Experimental GO EvidenceSwiss-Prot Reviewed	252
1527	CDC25C	cell division cycle 25C	5	Experimental GO EvidenceSwiss-Prot Reviewed	251
1528	COL18A1	collagen type XVIII alpha 1 chain	21	FDA Approved TargetOMIM Disease Gene	251
1529	NUMB	NUMB endocytic adaptor protein	14	Experimental GO EvidenceSwiss-Prot Reviewed	251
1530	PRSS1	serine protease 1	7	ProteaseOMIM Disease Gene	251
1531	PSMB1	proteasome 20S subunit beta 1	6	FDA Approved TargetOMIM Disease Gene	251
1532	RPL30	ribosomal protein L30	8	Highly ConstrainedFDA Approved Target	251
1533	SRPK1	SRSF protein kinase 1	6	KinaseExperimental GO Evidence	251
1534	SULT1A1	sulfotransferase family 1A member 1	16	Experimental GO EvidenceSwiss-Prot Reviewed	251
1535	AGTR2	angiotensin II receptor type 2	X	ReceptorClinical Trials	250
1536	CDK7	cyclin dependent kinase 7	5	DNA RepairKinase	250
1537	FADS2	fatty acid desaturase 2	11	TransporterExperimental GO Evidence	250
1538	FLNC	filamin C	7	OMIM Disease GeneVariant-Rich	250
1539	MBP	myelin basic protein	18	Experimental GO EvidenceSwiss-Prot Reviewed	250
1540	POU2F1	POU class 2 homeobox 1	1	Highly ConstrainedExperimental GO Evidence	250
1541	RFC1	replication factor C subunit 1	4	OMIM Disease GeneTrending	250
1542	TGFA	transforming growth factor alpha	2	Clinical TrialsExperimental GO Evidence	250
1543	BIN1	bridging integrator 1	2	OMIM Disease GeneExperimental GO Evidence	249
1544	CD63	CD63 molecule	12	TransporterTrending	249
1545	CKB	creatine kinase B	14	KinaseTrending	249
1546	CXCL13	C-X-C motif chemokine ligand 13	4	Experimental GO EvidenceSwiss-Prot Reviewed	249
1547	FLOT1	flotillin 1	6	TrendingExperimental GO Evidence	249
1548	FOXC1	forkhead box C1	6	Transcription FactorOMIM Disease Gene	249
1549	PLA2G4A	phospholipase A2 group IVA	1	Clinical TrialsOMIM Disease Gene	249
1550	PTPN2	protein tyrosine phosphatase non-receptor type 2	18	TrendingExperimental GO Evidence	249